Molina Juan L, Calvó María, Padilla Eduardo, Balda Mara, Alemán Gabriela González, Florenzano Néstor V, Guerrero Gonzalo, Kamis Danielle, Rangeon Beatriz Molina, Bourdieu Mercedes, Strejilevich Sergio A, Conesa Horacio A, Escobar Javier I, Zwir Igor, Cloninger C Robert, de Erausquin Gabriel A
Department of Psychiatry and Behavioral Neurosciences, Morsani College of Medicine, University of South Florida , Tampa, FL, USA.
Fundación de Lucha contra los Trastornos Neurológicos y Psiquiátricos en Minorías, FULTRA, Buenos Aires, Argentina; Hospital Neuropsiquiátrico Dr Néstor Sequeiros, San Salvador de Jujuy, Argentina.
NPJ Schizophr. 2017 Jan 11;3:16036. doi: 10.1038/npjschz.2016.36. eCollection 2017.
Identifying endophenotypes of schizophrenia is of critical importance and has profound implications on clinical practice. Here we propose an innovative approach to clarify the mechanims through which temperament and character deviance relates to risk for schizophrenia and predict long-term treatment outcomes. We recruited 61 antipsychotic naïve subjects with chronic schizophrenia, 99 unaffected relatives, and 68 healthy controls from rural communities in the Central Andes. Diagnosis was ascertained with the Schedules of Clinical Assessment in Neuropsychiatry; parkinsonian motor impairment was measured with the Unified Parkinson's Disease Rating Scale; mesencephalic parenchyma was evaluated with transcranial ultrasound; and personality traits were assessed using the Temperament and Character Inventory. Ten-year outcome data was available for ~40% of the index cases. Patients with schizophrenia had higher harm avoidance and self-transcendence (ST), and lower reward dependence (RD), cooperativeness (CO), and self-directedness (SD). Unaffected relatives had higher ST and lower CO and SD. Parkinsonism reliably predicted RD, CO, and SD after correcting for age and sex. The average duration of untreated psychosis (DUP) was over 5 years. Further, SD was anticorrelated with DUP and antipsychotic dosing at follow-up. Baseline DUP was related to antipsychotic dose-years. Further, 'explosive/borderline', 'methodical/obsessive', and 'disorganized/schizotypal' personality profiles were associated with increased risk of schizophrenia. Parkinsonism predicts core personality features and treatment outcomes in schizophrenia. Our study suggests that RD, CO, and SD are endophenotypes of the disease that may, in part, be mediated by dopaminergic function. Further, SD is an important determinant of treatment course and outcome.
识别精神分裂症的内表型至关重要,对临床实践具有深远影响。在此,我们提出一种创新方法,以阐明气质和性格偏差与精神分裂症风险相关的机制,并预测长期治疗结果。我们从安第斯山脉中部的农村社区招募了61名未使用过抗精神病药物的慢性精神分裂症患者、99名未患病亲属和68名健康对照者。通过神经精神病学临床评估量表确定诊断;用统一帕金森病评定量表测量帕金森运动障碍;用经颅超声评估中脑实质;并使用气质和性格量表评估人格特质。约40%的索引病例有十年的结局数据。精神分裂症患者的回避伤害和自我超越(ST)得分较高,而奖赏依赖(RD)、合作性(CO)和自我导向(SD)得分较低。未患病亲属的ST得分较高,CO和SD得分较低。在校正年龄和性别后,帕金森症可靠地预测了RD、CO和SD。未治疗精神病的平均持续时间(DUP)超过5年。此外,随访时SD与DUP和抗精神病药物剂量呈负相关。基线DUP与抗精神病药物剂量年数相关。此外,“爆发性/边缘型”、“有条理/强迫型”和“紊乱/分裂型”人格特征与精神分裂症风险增加有关。帕金森症可预测精神分裂症的核心人格特征和治疗结果。我们的研究表明,RD、CO和SD是该疾病的内表型,可能部分由多巴胺能功能介导。此外,SD是治疗过程和结果的重要决定因素。